Header links
Intranet
Donate now
image/svg+xml Map
Contact us

Rosario Pardo Diaz

Rosario Pardo Diaz

Institutions of which they are part

Research technician
Diabetes and Metabolism
Vall Hebron Institut de Recerca
Rosario Pardo Diaz

Rosario Pardo Diaz

Rosario Pardo Diaz

Institutions of which they are part

Research technician
Diabetes and Metabolism
Vall Hebron Institut de Recerca

Projects

Neuroprotección en la retinopatía diabética: una nueva estrategia terapéutica

IP: Rafael Simó Canonge
Collaborators: Rosario Pardo Diaz, Patricia Bogdanov Baruj, Laura Natalia Distefano
Funding agency: Ministerio Economía, Industria y Competitividad
Funding: 187200
Reference: SAF2012-35562
Duration: 01/01/2013 - 31/12/2015

Mecanismos moleculares de la restricción calórica en tejido adiposo blanco

IP: Josep A Villena Delgado
Collaborators: Rosario Pardo Diaz
Funding agency: Ministerio de Ciencia e Innovación-MICINN
Funding: 75020
Reference: SAF2011-23886
Duration: 01/01/2012 - 30/06/2013

Ministerio de Ciencia

Papel del coactivador PGC-1 beta en tejido adiposo blanco y su contribución al desarrollo de la obesidad y la diabetes de tipo 2

IP: Josep A Villena Delgado
Collaborators: Rosario Pardo Diaz
Funding agency: Ministerio de Ciencia e Innovación-MICINN
Funding: 168190
Reference: SAF2008-03644
Duration: 01/01/2009 - 31/03/2012

Ministerio de Ciencia

Related news

Dra. Julia Hernández Baixauli a l'entrega de l'ajut

A project led by Dr. Julia Hernández receives a grant from the ACD

The study is expected to contribute to the identification of new therapeutic targets and the development of nutritional strategies to improve health.

Research at VHIR

Four VHIR professionals receive funding from PERIS to intensify their research activity

The grants, amounting to more than €533,000 for VHIR, will allow clinical duties to be partially released over three years to promote strategic research projects in obesity, respiratory diseases, aortic pathology and metabolic fatty liver disease.

Equip de D-Sight

D-Sight launches its first-in-human clinical trial of eye neuroprotective therapies

The study will validate the safety of a novel topical ocular administration route for sitagliptin.

See more

Related professionals

Alberto Sandiumenge Camps

Alberto Sandiumenge Camps

Head of group
Donation and transplantation of organs, tissues and cells
Read more
Marina Pérez González

Marina Pérez González

Research technician
Neurovascular Diseases
Read more
Rubén López Ruiz

Rubén López Ruiz

Predoctoral researcher
Multidisciplinary Nursing Research Group
Read more
Victor Royo Calavera

Victor Royo Calavera

Gestió i Administració
Internal Strategy Directorate
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.